3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Gynecologic
1
Genitourinary
1
CNS
1
Breast
1
Conditions
Prostatic Neoplasms
692
Carcinoma, Renal Cell
228
Urinary Bladder Neoplasms
202
Carcinoma, Transitional Cell
112
Breast Neoplasms
96
Kidney Neoplasms
93
Neoplasms
84
Carcinoma, Non-Small-Cell Lung
82
Melanoma
79
Ovarian Neoplasms
77
Colorectal Neoplasms
70
Neoplasm Metastasis
66
Non-Muscle Invasive Bladder Neoplasms
57
Lung Neoplasms
53
Pancreatic Neoplasms
46
Sarcoma
45
Stomach Neoplasms
42
Endometrial Neoplasms
41
Uterine Cervical Neoplasms
39
Wilms Tumor
33
Adenocarcinoma
33
Carcinoma, Hepatocellular
32
Esophageal Neoplasms
31
Squamous Cell Carcinoma of Head and Neck
30
Triple Negative Breast Neoplasms
29
Head and Neck Neoplasms
27
Testicular Neoplasms
24
Metastatic Castration-resistant Prostate Cancer
24
Neuroblastoma
23
Colonic Neoplasms
23
Interventions
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Recurrence, Local
×
Genitourinary
×
90 days
×
Clear all
NCT07483658
2026-03-19
HYP-OP-RT
CHU de Quebec-Universite Laval
Phase NA
Not yet recruiting
434 enrolled